Guggenheim starts Verastem with a Buy, sees ‘potential deep value opportunity’
PremiumThe FlyGuggenheim starts Verastem with a Buy, sees ‘potential deep value opportunity’
1M ago
Verastem initiated with a Buy at Guggenheim
Premium
The Fly
Verastem initiated with a Buy at Guggenheim
1M ago
Verastem price target lowered to $7 from $17.50 at H.C. Wainwright
Premium
The Fly
Verastem price target lowered to $7 from $17.50 at H.C. Wainwright
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Verastem 13.333M share Spot Secondary priced at $3.00
Premium
The Fly
Verastem 13.333M share Spot Secondary priced at $3.00
3M ago
Verastem announces offering of common stock, warrants
Premium
The Fly
Verastem announces offering of common stock, warrants
3M ago
Verastem partner GenFleet says China’s NMPA approved clinical trial application
PremiumThe FlyVerastem partner GenFleet says China’s NMPA approved clinical trial application
5M ago
Verastem price target lowered to $20 from $34 at Alliance Global Partners
Premium
The Fly
Verastem price target lowered to $20 from $34 at Alliance Global Partners
5M ago
Verastem price target lowered to $16 from $32 at RBC Capital
Premium
The Fly
Verastem price target lowered to $16 from $32 at RBC Capital
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100